WHI-P180,153437-55-9

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

WHI-P180 hydrochloride

CAS No. : 153437-55-9

MCE 国际站：WHI-P180 hydrochloride

产品活性：WHI-P180 (Janex 3)是多种激酶抑制剂；抑制 RET，KDR 和 EGFR 的IC₅₀ 值分别为5 nM，66 nM 和4 μM。

研究领域：Protein Tyrosine Kinase/RTK  |  JAK/STAT Signaling

作用靶点：RET  |  VEGFR  |  EGFR

In Vivo: WHI-P180 is also an active inhibitor of IgE-mediated mast cell responses. The elimination half-life of WHI-P180 in CD-1 mice (BALB/c mice) following i.v., i.p., or p.o. administration is less than 10 min. Systemic clearance of WHI-P180 is 6742 mL/h/kg in CD-I mice and 8188 mL/h/kg in BALB/c mice. Notably, WHI-P180, when administered in two consecutive nontoxic i.p. bolus doses of 25 mg/kg, inhibits IgE/antigen-induced vascular hyperpermeability in a well-characterized murine model of passive cutaneous anaphylaxis.

相关产品：Sorafenib  |  Osimertinib  |  Trastuzumab  |  Gefitinib  |  Lenvatinib  |  Cetuximab  |  Erlotinib  |  Sunitinib  |  Regorafenib  |  Afatinib  |  Nintedanib  |  Bevacizumab  |  Semaxinib  |  Cabozantinib  |  Lapatinib  |  AG490  |  Ponatinib  |  Trastuzumab deruxtecan  |  Genistein  |  Axitinib  |  Neratinib  |  Midostaurin  |  Tucatinib  |  Chloramphenicol  |  Pazopanib  |  Trastuzumab emtansine  |  AG-1478  |  PD173074

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds